Towards Healthcare Research & Consulting
Erectile Dysfunction Treatment Market
Updated Date: 06 July 2026   |   Report Code: 6993

Erectile Dysfunction Treatment Market Rising Demand for Personalized Therapies to Boost USD 10.87 Billion by 2035

According to Rohan Patil, who specializes in erectile dysfunction causes, their treatment, and healthcare market intelligence, with5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in theerectile dysfunction treatment market.The global erectile dysfunction treatment market size was estimated at USD 4.98 billion in 2025 and is predicted to increase from USD 5.38 billion in 2026 to approximately USD 10.87 billion by 2035, expanding at a CAGR of 8.12% from 2026 to 2035.His analysis highlights a growing geriatric population, chronic disease burden, and flourishing ED treatment options. The research also examines the competitive strategies of key industry participants, includingFutura Medical plc, Vivus LLC,Pfizer Inc.,Eli Lilly and Company, Viatris Inc., and Bayer AG, shaping the future oferectile dysfunction treatment globally.

Last Updated : 06 July 2026 Category: Therapeutic Area Insight Code: 6993 Format: PDF / PPT / Excel

Content

Chapter 1: Introduction

  • Market Definition & Taxonomy
  • Research Objectives
  • Market Scope & Assumptions
  • Study Timeline (Historical, Base Year, Forecast Period)
  • Key Stakeholders Covered

Chapter 2: Research Methodology

  • Research Framework Overview
  • Market Size Estimation Methodology
    • Bottom-Up Approach
    • Top-Down Approach
  • Forecasting Model
    • Dependent Variables
    • Independent Variables
    • Key Assumptions & Weightages
  • Primary Research Insights
  • Secondary Data Sources
  • Data Validation & Triangulation

Chapter 3: Executive Summary

  • Global & Regional Overview (Value, CAGR)
  • Epidemiology Snapshot
  • Segmental Overview
  • Competition Key Snippets
  • Strategic Takeaways

Chapter 4: Market Catalysts, Constraints & Growth Levers

  • Market Dynamics
  • Market Drivers/Catalysts
    • Driver 1
    • Driver 2
  • Market Restraints
    • Restraint 1
    • Restraint 2
  • Market Opportunities
    • Opportunity 1
    • Opportunity 2
  • Market Trends
    • Trend 1
    • Trend 2
  • Impact Assessment of Drivers, Restraints, Opportunities & Trends (High, Mid, & Low)

Chapter 5: Value Added Intelligence

  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers: Low/Moderate/High
    • Bargaining Power of Buyers: Low/Moderate/High
    • Threat of New Entrants: Low/Moderate/High
    • Threat of Substitute: Low/Moderate/High
    • Competitive Rivalry: Low/Moderate/High
  • PESTEL Analysis
  • Ecosystem Analysis
  • Mapping of Key Players
  • Value Chain Analysis
  • Margin Analysis Across Value Chain
  • Macro & Micro Factors Impacting Market
  • Market Potential Evaluation, By Region
  • Epidemiology & Patient Pool Analysis
    • Disease Incidence & Prevalence
    • Target Patient Pool
      • Diagnosed Population
      • Service-Seeking Population
    • Patient Flow & Utilization Analysis
      • Patient Footfall
      • Admission Rates
      • Procedure Volume
    • Healthcare Infrastructure Analysis
      • Number of Facilities
        • Hospitals
        • Clinics
        • Diagnostic Centers
        • ASCs
      • Bed Capacity
        • Total Beds
        • ICU Beds
      • Facility Distribution
    • Operational Metrics Analysis
      • Bed Occupancy Rate (%)
      • Average Length of Stay (ALOS)
    • Service Pricing & Revenue Model
      • Pricing Analysis
        • Cost per Procedure
        • Cost per Consultation
        • Cost per Diagnostic Test
      • Revenue Streams
        • Inpatient Services
        • Outpatient Services
        • Ancillary Services
      • Workforce & Staffing Analysis
        • Healthcare Workforce
          • Physicians
          • Nurses
          • Technicians
        • Staff-to-Patient Ratios
        • Skill Gap Analysis
        • Labor Cost Structure
      • Scenario Analysis (Base / Optimistic / Pessimistic)
      • Risk Assessment & Sensitivity Analysis
      • Opportunity Analysis, By Region
      • Regulatory Analysis
      • Sustainability & ESG Insights
      • Business Models
      • Investment & Funding Landscape
      • Key Conferences and Events

Chapter 7: Segmental & Regional Analysis

  • Erectile Dysfunction Treatment Market Analysis, By Treatment Type
    • Market Size, Forecast & CAGR, By Treatment Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Erectile Dysfunction Treatment Market Analysis, By Etiology
    • Market Size, Forecast & CAGR, By Treatment Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Erectile Dysfunction Treatment Market Analysis, By Route of Administration
    • Market Size, Forecast & CAGR,By Treatment Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Erectile Dysfunction Treatment Market Analysis, By Distribution Channel
    • Market Size, Forecast & CAGR,By Treatment Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis
  • Erectile Dysfunction Treatment Market Analysis, By End User
    • Market Size, Forecast & CAGR,By Treatment Type, 2022-2035
    • Key Rationale
    • Y-o-Y Analysis

Chapter 6: Competitive Insights

  • Competitive Analysis
    • Company Evaluation Matrix
      • Major Players
      • Mid-Sized Companies
      • Emerging Players/Start-Ups
    • Global Market Share Analysis, By Region, 2025 (%)
    • Key Player Positioning
    • Competitive Benchmarking
      • By Treatment Type
      • By Etiology
      • By Route of Administration
      • By Distribution Channel
      • By End User
    • Strategies of Key Players
    • Insight From the Horse’s Mouth
  • Company Profiles
    • Pfizer Inc.
      • Company Name
      • Company Headquarters
      • Management Overview
        • Key C-Suite Executives
          • CEO
          • MD
          • Others
        • Employee Count
        • Business Strategy
          • Key Investments Made
          • Future Plans
          • R&D & Innovation Capabilities
          • Recent Developments
            • New Product Launch
            • Merger & Acquisitions
            • Partnerships & Collaborations
            • Market Expansion
            • Others
          • Service Portfolio
          • Facility Network
            • Number of Facilities
            • Bed Capacity
            • Facility Distribution
            • Expansion Pipeline
          • Key Financials (2022-2025)
            • Revenue By Segment
            • Revenue By Service
            • Revenue By Geography
            • Financial Matrix (Gross Profit Margins, Net Margins, etc.)
          • Key Clients
            • Client Company Name
            • Key Contact Person
            • Contact Details
          • Regulatory & Certification Expertise
          • SWOT Analysis
    • Vivus LLC
    • Eli Lilly And Company
    • Petros Pharmaceuticals, Inc.
    • Bayer AG
    • Viatris Inc.
    • Futura Medical plc

FAQ's

Answer : The erectile dysfunction treatment market in 2026 is valued at USD 5.38 billion and is projected to climb to USD 10.87 billion by 2035, with a CAGR of 8.12% over the forecast period.

Answer : Strategic Science & Technologies contributed to the market growth by providing SST-6006, which is a topical sildenafil cream.

Answer : Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar